SARS-CoV-2 IS MOST LIKELY A WORK-IN-PROGRESS VACCINE FOR HIV

April 29, 2021

NOBEL LAUREATE LUC MONTAGNIER WAS RIGHT ALL ALONG. SARS-CoV-2 IS MOST LIKELY A WORK-IN-PROGRESS VACCINE FOR HIV. (DUAL PURPOSE BIOWEAPON)

Please read the referenced paper. The hypothesis is that, although LINE1 and EREs (endogenous retrotransposable elements) are expressed and indicate poor prognosis in and for certain cancers, vaccination with these elements have been shown to be safe and immunogenic – with great potential for HIV.

T cell lines targeting these antigens are capable of killing autologous HIV-1–infected, but not uninfected cells, independently of the HIV-1 clade.  These studies open the possibility that ERE Antigens might be useful surrogate targets for vaccination against HIV-1.

Indeed, the authors of the paper realized that selecting the correct elements will be challenging. The danger is expressing these elements in HEALTHY cells, rendering them targets. Ultimately, this potential raises the safety concerns of INDUCING AUTOIMMUNE DISORDERS or IMMUNE COMPLEX DISEASE by ERE-based vaccines and immunotherapies.

If you review the table of where antibodies FOUND these Human Endogenous Retroviruses they are in EXACTLY the organs which SARS-CoV-2 targets.

So, which are we dealing with? An escaped vaccine in progress? Or, an escaped (?) bioweapon which knowingly awakens our immune system to destroy human DNA.

Disclosures

The referenced study was sponsored by Pfizer and comprises both internal research and work conducted in collaboration with Pfizer funding.

Referenced/Related Papers

Vaccination with Cancer- and HIV Infection-Associated Endogenous Retrotransposable Elements Is Safe and Immunogenic

https://jimmunol.org/content/jimmunol/189/3/1467.full.pdf